Company intelligence / Profile preview

CognifiSense

Sunnyvale, California, United Statescognifisense.com ↗

Ownership: Private
Development stage: Commercial

Overview

CognifiSense’s VRNT platform is FDA-cleared and clinically proven to reduce chronic pain by retraining the brain’s processing of pain signals. The therapy uses immersive virtual reality experiences to break maladaptive neural patterns associated with persistent pain, offering non-invasive, opioid-free relief. Clinical results have shown significant reductions in chronic pain intensity and improved patient function through at-home use of standard VR equipment.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapyVirtual reality-based therapy
Industry: Digital Health Medical Devices

Partnerships

Collaborations with physicians, therapists, and researchers for clinical development and improvement of VRNT

Beyond the preview

Go deeper on CognifiSense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CognifiSense.

Explore the full profile